Search Results - Javier Bolaños‐Meade

Refine Results
  1. 1
    Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases

    Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases by Robert A. Brodsky, Leo Luznik, Javier Bolaños‐Meade, Mary S. Leffell, Richard J. Jones, Ephraim J. Fuchs

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease

    HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease by Javier Bolaños‐Meade, Ephraim J. Fuchs, Leo Luznik, Sophie Lanzkron, Christopher Gamper, Richard J. Jones, Robert A. Brodsky

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Graft-versus-Host Disease Treatment: Predictors of Survival

    Graft-versus-Host Disease Treatment: Predictors of Survival by John E. Levine, Brent R. Logan, Juan Wu, Amin M. Alousi, Vincent T. Ho, Javier Bolaños‐Meade, Daniel J. Weisdorf

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    5-Azacytidine as Salvage Treatment in Relapsed Myeloid Tumors after Allogeneic Bone Marrow Transplantation

    5-Azacytidine as Salvage Treatment in Relapsed Myeloid Tumors after Allogeneic Bone Marrow Transplantation by Javier Bolaños‐Meade, Benjamin D. Smith, Steven D. Gore, Michael A. McDevitt, Leo Luznik, Ephraim J. Fuchs, Richard J. Jones

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study

    Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study by John E. Levine, Brent R. Logan, Juan Wu, Amin M. Alousi, Javier Bolaños‐Meade, James L.M. Ferrara, Vincent T. Ho, Daniel J. Weisdorf, Sophie Paczesny

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

    Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide by Christopher G. Kanakry, Sudipto Ganguly, Marianna Zahurak, Javier Bolaños‐Meade, Christopher J. Thoburn, Brandy Perkins, Ephraim J. Fuchs, Richard J. Jones, Allan D. Hess, Leo Luznik

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Pentostatin in Steroid-Refractory Acute Graft-Versus-Host Disease

    Pentostatin in Steroid-Refractory Acute Graft-Versus-Host Disease by Javier Bolaños‐Meade, David A. Jacobsohn, Jeffrey Margolis, Adam Ogden, M. Guillaume Wientjes, John C. Byrd, David Lucas, Viki Anders, Michele Phelps, Michael R. Grever, Georgia B. Vogelsang

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study

    A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study by John E. Levine, Thomas M. Braun, Andrew C. Harris, Ernst Holler, Austin Taylor, Holly Miller, John Magenau, Daniel J. Weisdorf, Vincent T. Ho, Javier Bolaños‐Meade, Amin M. Alousi, James L.M. Ferrara

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow Transplantation

    HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow Transplantation by Amer M. Zeidan, Patrick M. Forde, Heather J. Symons, Allen Chen, Benjamin D. Smith, Keith W. Pratz, Hetty E. Carraway, Douglas E. Gladstone, Ephraim J. Fuchs, Leo Luznik, Richard J. Jones, Javier Bolaños‐Meade

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Phase II Study of Risk-Adapted Therapy of Newly Diagnosed, Aggressive Non-Hodgkin Lymphoma Based on Midtreatment FDG-PET Scanning

    Phase II Study of Risk-Adapted Therapy of Newly Diagnosed, Aggressive Non-Hodgkin Lymphoma Based on Midtreatment FDG-PET Scanning by Yvette L. Kasamon, Richard L. Wahl, Harvey A. Ziessman, Amanda L. Blackford, Steven N. Goodman, Caroline A. Fidyk, Kathryn Rogers, Javier Bolaños‐Meade, Michael J. Borowitz, Richard F. Ambinder, Richard J. Jones, Lode J. Swinnen

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

    Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clin... by Amin M. Alousi, Daniel J. Weisdorf, Brent R. Logan, Javier Bolaños‐Meade, Shelly Carter, Nancy DiFronzo, Marcelo C. Pasquini, Steven C. Goldstein, Vincent T. Ho, Brandon Hayes‐Lattin, John R. Wingard, Mary M. Horowitz, John E. Levine

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation

    American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation by Julie Kanter, Robert I. Liem, Françoise Bernaudin, Javier Bolaños‐Meade, Courtney D. Fitzhugh, Jane S. Hankins, M. Hassan Murad, Julie A. Panepinto, Damiano Rondelli, Shalini Shenoy, John E. Wagner, Mark C. Walters, Teonna Woolford, Joerg J Meerpohl, John F. Tisdale

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Outcomes of Related Donor HLA-Identical or HLA-Haploidentical Allogeneic Blood or Marrow Transplantation for Peripheral T Cell Lymphoma

    Outcomes of Related Donor HLA-Identical or HLA-Haploidentical Allogeneic Blood or Marrow Transplantation for Peripheral T Cell Lymphoma by Jennifer A. Kanakry, Yvette L. Kasamon, Christopher D. Gocke, Hua-Ling Tsai, Janice Davis‐Sproul, Nilanjan Ghosh, Heather J. Symons, Javier Bolaños‐Meade, Douglas E. Gladstone, Lode J. Swinnen, Leo Luznik, Ephraim J. Fuchs, Richard J. Jones, Richard F. Ambinder

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

    Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide by Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños‐Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia

    Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia by Judith E. Karp, Amanda L. Blackford, B. Douglas Smith, Katrina Alino, Amy Hatfield Seung, Javier Bolaños‐Meade, Jacqueline M. Greer, Hetty E. Carraway, Steven D. Gore, Richard J. Jones, Mark J. Levis, Michael A. McDevitt, L. Austin Doyle, James R. Wright

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide

    Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosph... by Shannon R. McCurdy, Christopher G. Kanakry, Hua-Ling Tsai, Yvette L. Kasamon, Margaret M. Showel, Javier Bolaños‐Meade, Carol Ann Huff, Ivan Borrello, William Matsui, Robert A. Brodsky, Richard F. Ambinder, Maria Bettinotti, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study

    Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study by Mary Eapen, Ruta Brazauskas, Mark C. Walters, Françoise Bernaudin, Khalid Bo-Subait, Courtney D. Fitzhugh, Jane S. Hankins, Julie Kanter, Joerg J Meerpohl, Javier Bolaños‐Meade, Julie A. Panepinto, Damiano Rondelli, Shalini Shenoy, Joi Williamson, Teonna Woolford, Éliane Gluckman, John E. Wagner, John F. Tisdale

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

    Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation by John R. Wingard, Shelly L. Carter, Thomas J. Walsh, Joanne Kurtzberg, Trudy N. Small, Lindsey R. Baden, Iris D. Gersten, Adam Mendizabal, Helen Leather, Dennis L. Confer, Richard T. Maziarz, Edward A. Stadtmauer, Javier Bolaños‐Meade, J. Martin Brown, John F. DiPersio, Michael Boeckh, Kieren A. Marr

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

    High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease by Leo Luznik, Javier Bolaños‐Meade, Marianna Zahurak, Allen Chen, B. Douglas Smith, Robert A. Brodsky, Carol Ann Huff, Ivan Borrello, William Matsui, Jonathan D. Powell, Yvette L. Kasamon, Steven N. Goodman, Allan D. Hess, Hyam I. Levitsky, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation

    Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation by Yvette L. Kasamon, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Heather J. Symons, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Robert A. Brodsky, William Matsui, Ivan Borrello, Satish Shanbhag, Kenneth R. Cooke, Richard F. Ambinder, Leo Luznik, Javier Bolaños‐Meade, Richard J. Jones

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: